Clinical trial Recruiting at 1 site Observational Ages 18 and up

Improving drug adherence in cancer patients through a multidisciplinary consultation program

Official title: Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment

Run by Centre Hospitalier Universitaire, Amiens · NCT04797143 · Data updated 2026-11-12

This study tests whether a special consultation program can help cancer patients stick to their oral medication plans better by addressing their challenges.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedMarch 11, 2021
Main results expectedMarch 2026
Study endsMarch 2026
Registry record updatedApril 2, 2025
Trial IDNCT04797143 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are French-speaking patients with newly diagnosed or relapsed cancer starting oral anticancer treatment.

Probably not a fit

Patients receiving hormone therapy only or those with severe psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of a multidisciplinary consultation program on drug adherence among patients undergoing their first oral anticancer treatment. It focuses on identifying barriers to adherence, such as access to medications, adverse effects, and complex regimens. The study measures drug adherence using the medication possession ratio (MPR) before and after implementing the consultation program. The goal is to enhance medication management and reduce healthcare costs associated with nonadherence.

Why it matters

Potential benefit: If successful, this program could significantly improve drug adherence and treatment outcomes for cancer patients on oral therapies.

How similar studies have gone: Other studies have shown that multidisciplinary approaches can improve medication adherence, suggesting potential success for this program.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* French speaking patients with a newly diagnosed or relapsed cancer, regardless of location and introduction of oral anticancer treatment

Exclusion Criteria:

* patients treated with hormone therapy only
* Patient with severe psychiatric disorders
* patient who does not speak the French language

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.